Skin, Hair & Anti-Aging

A naturally occurring copper-binding tripeptide widely used in cosmetics and studied for skin remodeling and wound healing.

A four-amino-acid peptide studied primarily in Russian and Eastern European research for longevity, sleep, and antioxidant effects.

A cyclic melanocortin receptor agonist that increases skin pigmentation; precursor research peptide that led to bremelanotide.

A 28-amino-acid immunomodulatory peptide approved in many countries (as Zadaxin) for hepatitis B and as an adjunct in cancer and infection.

A human cathelicidin antimicrobial peptide central to skin and respiratory innate immunity.

The C-terminal tripeptide of α-MSH studied for anti-inflammatory effects in gut and skin disease.

A linear analog of α-melanocyte-stimulating hormone (α-MSH) that activates the melanocortin-1 receptor to stimulate eumelanin production. As the drug afamelanotide (SCENESSE), it is FDA-approved for a rare light-sensitivity disorder; the grey-market 'tanning peptide' sold under this name is unapproved.

A skin-and-recovery research blend combining the copper peptide GHK-Cu with TB-500 and BPC-157, marketed for skin quality and tissue repair. GHK-Cu has human cosmetic data; the other two are animal-only, and the combination is untested.

An anti-inflammatory extension of the Glow blend that adds KPV (an α-MSH fragment) to GHK-Cu, TB-500, and BPC-157, aiming to combine skin remodeling, tissue repair, and inflammation control. The four-peptide combination is untested in humans.